跳至主要内容
临床试验/NCT01517425
NCT01517425Enrolling By Invitation不适用

Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells

Scripps Translational Science Institute1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
200
试验地点
1
主要终点
iPSC development

研究概览

简要总结

This research is being done to understand how changes in DNA may put people at risk for developing coronary artery disease. Stem cells will be made using cells from blood and/or skin biopsy samples. We are trying to understand which specific changes in DNA negatively impact a person's health.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Previously enrolled in the CAD module of the Genebank at Scripps Clinic Registry
  • Eligible to have their blood drawn
  • Be reliable, cooperative and willing to comply with all protocol-specified procedures
  • Able to understand and grant informed consent
  • Previously enrolled in the Healthy Elderly Active Longevity (HEAL) Cohort
  • Eligible to have their blood drawn
  • Be reliable, cooperative and willing to comply with all protocol-specified procedures
  • Able to understand and grant informed consent

排除标准

  • Unwilling or unable to grant informed consent.
  • Have a significant medical condition that in the Investigator's opinion may interfere with subject's study participation.

结局指标

主要结局

iPSC development

时间窗: five years

Develop methods of iPSC generation from patients with genomic risk.

次要结局

未报告次要终点

研究者

发起方
Scripps Translational Science Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Topol, MD

Director, Scripps Translational Science Institute

Scripps Translational Science Institute

研究点 (1)

Loading locations...

相似试验